Patrys Limited (PAB) is focused on the development of natural human antibody-based therapies for the treatment of cancer. The company is also exploring opportunities to deploy its technologies in additional indications, either internally or through third parties, including cardiovascular, autoimmune and central nervous system disorders.
PAB – Patrys Limited
Be the first to comment